Kim, Chong, MD

Kim, Chong, MD

PROFESSIONAL AFFILIATIONS

Investigator
Cleveland FES Center

Director, Division of Musculoskeletal Rehabilitation
Medical Director, Spine Center
MetroHealth System

Program Director, Pain Medicine Fellowship
Case Western Reserve University School of Medicine/MetroHealth

Professor, Department of Physical Medicine
Case Western Reserve University

CONTACT INFORMATION

Program Contact:
Chong Kim

Phone: 
(216) 696-3876

Email:
chk56@case.edu

PUBLICATIONS

Dr. Chong Kim is a physiatrist and pain management specialist with extensive clinical and research experience in chronic pain and spine conditions, particularly interventional pain procedures and neuromodulation.

He currently serves as Director of the Division of Musculoskeletal Rehabilitation and as Medical Director of the Spine Center at MetroHealth System.

Dr. Kim also directs the Pain Medicine Fellowship at Case Western Reserve University School of Medicine/MetroHealth. His expertise encompasses clinical trials evaluating the implantation and use of spinal cord stimulation for pain treatment, with a special focus on novel targets and neuromodulation approaches for refractory pain.

RESEARCH PROGRAMS

Dr. Kim’s research centers on neuromodulation techniques for pain management, with a focus on spinal cord stimulation and novel electrode placements. His clinical studies explore the use of neuromodulation in spine-related pain, peripheral nerve stimulation, and advanced programming strategies for device trials and revisions. Dr. Kim’s team investigates both clinical outcomes and mechanistic approaches, aiming to refine pain relief strategies for complex conditions.

MAJOR PROJECTS & FUNDING

Dr. Kim has served as principal investigator or co-investigator on numerous clinical trials evaluating spinal cord stimulation and neuromodulation for various pain conditions. His recent publications highlight combined dorsal and ventral spinal cord stimulation for refractory neuropathic pain, multicenter studies utilizing intraoperative neuromonitoring, and the use of mechanical gateway connectors in device trials. He continues to collaborate on studies that advance neuromodulation technology and its clinical application.